Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds